Fee-for-Service Research

Publisher Website
Google Scholar
Abstract
The introduction of a new medical treatment into clinical practice often necessitates spending a large amount of money on both basic and clinical research. Such research costs are usually borne by granting agencies or industry. It appears that efforts are under way to use a new source of funding for clinical research: the patient. Since these efforts will be directed not at the general public but at a specific patient suffering from a particular disease, they differ from the standard disease-oriented fund-raising campaigns.A close, mutually beneficial relationship between industry and medicine has been an important factor in the introduction . . .